A study of prescription pattern of drugs used in the treatment of osteoarthritis in tertiary care teaching  hospitals

Mukesh Kumar; Shaktibala Dutta; Jyotsna Sharma; Vaishali Babasaheb Lote

doi:10.53730/ijhs.v6nS4.10761

Authors

Mukesh Kumar
mukeshkumar4074@gmail.com
Phd Scholar, Santosh Medical College Ghaziabad, Uttar Pradesh, India
Shaktibala Dutta Professor & Head Department of Pharmacology SMC Ghaziabad, Uttar Pradesh, India
Jyotsna Sharma Professor Department of Pharmacology SMC Ghaziabad, Uttar Pradesh, India
Vaishali Babasaheb Lote Assistant Professor Department of Pharmacology SMC Ghaziabad, Uttar Pradesh, India

Keywords:

osteoarthritis, NSAID, SYSADOA, EULAR, OARSI

Abstract

Background: Evaluation of drug utilization patterns need to be done consistently to facilitate obligatory modifications in prescription pattern of drug to hike the therapeutic benefit and to lessen the adverse effects. Osteoarthritis (OA) is becoming growingly acknowledged as a leading reason of chronic pain and lower limb disability amid the elderly people . There are a very few studies which assess the pattern of drug utilization in newly diagnosed osteoarthritis. So the aim & objective of this research is to study & analyze the recent trends in pattern of drug prescription in newly diagnosed osteoarthritis patients . Methods : It was Prospective, Observational study , newly diagnosed patients with osteoarthritis were enrolled in the study considering the inclusion and exclusion criteria. Data was recorded in a specially designed proforma . Results: NSAIDs were most common prescribed class of drugs which were used in all prescriptions. Paracetamol was used in 73% prescriptions but always in combination with NSAIDs. Tramadol was used in 6%prescriptions. Corticosteroids were used in 7% of prescriptions. SYSADOAs were used in 13.5% prescriptions. Non-pharmacological measures like physiotherapy is not advised to any patient.

Downloads

Download data is not yet available.

References

Abramson SB. The role of NSAIDS in the treatment of osteoarthritis. In Osteoarthritis. Edited by: Brandt KD, Doherty M, Lohmander LS. Oxford: Oxford University Press; 2003:251-8.

Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Åberg H, et al. Drug utilization 90%– a simple method for assessing the quality of drug prescribing. European J clinical pharmacology. 1998;54(2):113-8.

Bernatsky S, Feldman D, Civita MD, Haggerty J, Tousignant P, Legare J, et al. Clin Rheumatol. 2010;29:645-57.

David JH, Victoria LJ. The Epidemiology of Osteoarthritis; Best Practice and Research. Clinical Rheumatology. 2014;28:5-15.

Dyer E, Heflin MT.Osteoarthritis: its course in older patients and current treatment methods. Clinical Geriatrics. 2005;13(7):18.

Estevez, A. G., Espinosa, A. H. R., Rodríguez, D. L., & Leyva, T. F. (2019). Current approaches and controversies: legalization and non-legalization of drugs. International Journal of Health & Medical Sciences, 2(1), 26-32. https://doi.org/10.31295/ijhms.v2n1.85

Goldring SR, Goldring MB. Clinical aspects, pathology and pathophysiology of osteoarthritis. J Musculoskeletal Neuronal Interaction. 2006;6(4):376

Gupta R, Malhotra A, MalhotrP. Study of prescription pattern of drugs used in the treatment of osteoarthritis in a tertiary care teaching hospital-an observational study. Int J Res Med Sci 2018;6:985-9.

Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR Recommendations 2003: an evidence-based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Annals rheumatic diseases. 2003;62(12):1145-55.

Lahamate B S , Razvi US. To study prescription pattern in the management of osteoarthritis in tertiary care hospital . Asian j Pharm Clin Res.2020;13(6):87-92.

Lohmander LS, de Verdier MG, Rollof J, Nilsson PM, Engstrom G. Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Annals Rheumatic Diseases. 2009;68(4):490- 496.

Lohmander LS, Roos EM. Clinical update: treating osteoarthritis. The Lancet .2008;370(96):2082-2084.

Mohamed A, Nahid A, Zia RU, Misbahullah K. A study on prescribing patterns in the management of arthritis in the department of Orthopaedics. Scholars Research Library. 2012;4(1):5-27.

Muirden KD. Community oriented program for the control of Rheumatic diseases: Studies of rheumatic diseases in the developing world. Curr opin Rheumatol. 2005;17:153-6.

Pavelka K, Trč T, Karpaš K, Sedláčková M, Vlasáková V, Böhmová J, et al. The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: A randomized, multicenter, double‐blind, placebo‐controlled study with primary end points at two months after the end of a three‐month treatment period. Arthritis Rheumatology. 2007;56(12):4055-64.

Recommendations, EULAR. An evidence-based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145-55.

Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. The Lancet. 2001;357(9252):251-6.

Rintelen B, Neumann K, Leeb BF. A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Archives Internal Med. 2006;166(17):1899-906.

Sam Anbu Sahayam J*, Kulandaiammal M, Prakash M. PATTERN OF DRUG PRESCRIBING IN OSTEOARTHRITIS PATIENTS ATTENDING ORTHOPAEDIC OUTPATIENT DEPARTMENT OF A TERTIARY CARE HOSPITAL.Journal of Drug delivery & therapeutics. 2016;6(5):14-17.

Sam S, Anbu J, Kulandaiammal M, Prakash M. Pattern of drug prescribing in osteoarthritis patients attending orthopaedic outpatient department of a tertiary care hospital. J Drug Delivery Therapeutics. 2016;6(5):14-17.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949

Toegel S, Wu SQ, Piana C, Unger FM, Wirth M, Goldring MB, et al. Comparison between chondroprotective effects of glucosamine, curcumin, and diacerein in IL-1β-stimulated C-28/I2 chondrocytes. Osteoarthritiscartilage. 2008;16(10):1205-12.

Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis (Cochrane review): In: Cochrane Library. Issue 2. In: Oxford: Update Software, 2001.

ULLAL S D, NARENDRANATH S, KAMATH R K, PAI MRSM KAMATH S U, SAVUR AMARNATH D. Prescribing pattern for osteoarthritis in a tertiary care hospital. Journal of Clinical and Diagnostic Research.2010;7 (4):2421-26

Velentina BP. Pharmacy practice. 2009;7(2):88-93.

Yuen YH, Chang S, Chong CK, Lee SC, Critchlev JA, Chan JC. Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther 1998; 23:287-94

Yuen YH, Chang S, Chong CK, Lee SC, Critchlev JA, Chan JC. Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther. 1998;23:287-94.

Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage. 2008;16(2):137-62.